Jordana E. Hoppe - Concepedia

Author

Jordana E. Hoppe

University of Colorado Denver ORCID

Also Known As

J Hoppe, J. Ellway Hoppe, J. Hoppe, Jordana E Hoppe, Jordana E. Hoppe, Jordana Hoppe

Publications

582

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver Children's Hospital Colorado University of Washington Colorado School of Public Health University of Colorado Anschutz Medical Campus

About

Jordana E. Hoppe is an author at University of Colorado Denver specializing in medicine, pulmonary fibrosis, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	152
2	Immunology	1	1	16
3	Pathology	1	1	16
4	Pulmonary Medicine	1	1	20
5	Antibiotics	1	1	20

Jordana E. Hoppe

Publications

472

Citations

H-Index

Page 1

	Year	Citations
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, The Lancet Respiratory Medicine MedicineHypertonic SalineDornase AlfaPulmonary Fibrosis	2022	116
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele Jennifer L. Goralski, Jordana E. Hoppe, Marcus Mall, American Journal of Respiratory and Critical Care Medicine	2023	113
Sputum induction improves detection of pathogens in children with cystic fibrosis Jordana E. Hoppe, E. Towler, Brandie D. Wagner, Pediatric Pulmonology	2015	40
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial Jordana E. Hoppe, Ajay S. Kasi, Jessica E. Pittman, The Lancet Respiratory Medicine	2025	39
Evaluation of surrogate measures of pulmonary function derived from electrical impedance tomography data in children with cystic fibrosis Peter A. Muller, Jennifer L. Mueller, Michelle M. Mellenthin, Physiological Measurement	2018	36
Airway Inflammation in Children with Primary Ciliary Dyskinesia Scott D. Sagel, Oren Kupfer, Brandie D. Wagner, Annals of the American Thoracic Society	2022	21
Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis Jordana E. Hoppe, Brandie D. Wagner, Frank J. Accurso, Journal of Cystic Fibrosis AntibioticsPulmonary ExacerbationsPediatricsRespiratory InfectionPediatric Lung Disease	2018	20
Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis P. Lenhart-Pendergrass, Meg Anthony, Sabina Sariyska, Pediatric Pulmonology	2021	19
Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis Stacey L. Martiniano, Scott D. Sagel, Michael V. Zaretsky, Journal of Cystic Fibrosis	2024	18
Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D Jordana E. Hoppe, Brandie D. Wagner, J. Kirk Harris, Journal of Cystic Fibrosis InflammationChronic Inflammatory DiseasesCytokineAnti-inflammatoryAutoimmune Disease	2022	16

Page 1